108 related articles for article (PubMed ID: 25738398)
21. Altered distribution of beta-catenin and prognostic roles in colorectal carcinogenesis.
Chen S; Liu J; Li G; Mo F; Xu X; Zhang T; Zhang X; Li J; Han X; Sun Y
Scand J Gastroenterol; 2008; 43(4):456-64. PubMed ID: 18365911
[TBL] [Abstract][Full Text] [Related]
22. Relationship between osteopontin and β-catenin immunohistochemical expression and prognostic parameters of colorectal carcinoma.
Youssef NS; Osman WM
Int J Clin Exp Pathol; 2015; 8(2):1503-14. PubMed ID: 25973035
[TBL] [Abstract][Full Text] [Related]
23. Beta-catenin and p53 expression in topographic compartments of colorectal cancer and its prognostic value following surgery.
Prieto JD; Álvarez M; Hierro MI; García I; Vicioso L
Ann Diagn Pathol; 2017 Dec; 31():1-8. PubMed ID: 29146051
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathologic and carcinogenetic appraisal of DNA replication error in sporadic T3N0M0 stage colorectal cancer after curative resection.
Liang JT; Chang KJ; Chen JC; Lee CC; Cheng YM; Hsu HC; Chien CT; Wang SM
Hepatogastroenterology; 1999; 46(26):883-90. PubMed ID: 10370632
[TBL] [Abstract][Full Text] [Related]
25. Correlations between TBL1XR1 and recurrence of colorectal cancer.
Liu H; Xu Y; Zhang Q; Li K; Wang D; Li S; Ning S; Yang H; Shi W; Liu Z; Chen Y
Sci Rep; 2017 Mar; 7():44275. PubMed ID: 28295012
[TBL] [Abstract][Full Text] [Related]
26. Low expression of CysLT1R and high expression of CysLT2R mediate good prognosis in colorectal cancer.
Magnusson C; Mezhybovska M; Lörinc E; Fernebro E; Nilbert M; Sjölander A
Eur J Cancer; 2010 Mar; 46(4):826-35. PubMed ID: 20064706
[TBL] [Abstract][Full Text] [Related]
27. Reduced expression of alpha catenin is associated with poor prognosis in colorectal carcinoma.
Ropponen KM; Eskelinen MJ; Lipponen PK; Alhava EM; Kosma VM
J Clin Pathol; 1999 Jan; 52(1):10-6. PubMed ID: 10343606
[TBL] [Abstract][Full Text] [Related]
28. Prognostic values of osteopontin-c, E-cadherin and β-catenin in breast cancer.
Pang H; Lu H; Song H; Meng Q; Zhao Y; Liu N; Lan F; Liu Y; Yan S; Dong X; Cai L
Cancer Epidemiol; 2013 Dec; 37(6):985-92. PubMed ID: 24012693
[TBL] [Abstract][Full Text] [Related]
29. GPR48, a poor prognostic factor, promotes tumor metastasis and activates β-catenin/TCF signaling in colorectal cancer.
Wu J; Xie N; Xie K; Zeng J; Cheng L; Lei Y; Liu Y; Song L; Dong D; Chen Y; Zeng R; Nice EC; Huang C; Wei Y
Carcinogenesis; 2013 Dec; 34(12):2861-9. PubMed ID: 23803691
[TBL] [Abstract][Full Text] [Related]
30. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
[TBL] [Abstract][Full Text] [Related]
31. Cytoplasmic beta-catenin accumulation is a good prognostic marker in upper and lower gastrointestinal adenocarcinomas.
Norwood MG; Bailey N; Nanji M; Gillies RS; Nicholson A; Ubhi S; Darnton JJ; Steyn RS; Womack C; Hughes A; Hemingway D; Harrison R; Waters R; Jankowski JA
Histopathology; 2010 Jul; 57(1):101-11. PubMed ID: 20572881
[TBL] [Abstract][Full Text] [Related]
32. High expression of anti-apoptotic protein Bcl-2 is a good prognostic factor in colorectal cancer: Result of a meta-analysis.
Huang Q; Li S; Cheng P; Deng M; He X; Wang Z; Yang CH; Zhao XY; Huang J
World J Gastroenterol; 2017 Jul; 23(27):5018-5033. PubMed ID: 28785155
[TBL] [Abstract][Full Text] [Related]
33. Tumour necrosis factor-alpha and transforming growth factor-beta are significantly associated with better prognosis in non-small cell lung carcinoma: putative relation with BCL-2-mediated neovascularization.
Boldrini L; Calcinai A; Samaritani E; Pistolesi F; Mussi A; Lucchi M; Angeletti CA; Basolo F; Fontanini G
Br J Cancer; 2000 Aug; 83(4):480-6. PubMed ID: 10945495
[TBL] [Abstract][Full Text] [Related]
34. Relationship between β-catenin expression and prognostic parameters of colorectal carcinomas.
Peker K; Başoğlu M; Gürsan N
Turk Patoloji Derg; 2013; 29(2):87-93. PubMed ID: 23661344
[TBL] [Abstract][Full Text] [Related]
35. Association between recurrence of sporadic colorectal cancer, high level of microsatellite instability, and loss of heterozygosity at chromosome 18q.
Sarli L; Bottarelli L; Bader G; Iusco D; Pizzi S; Costi R; D'Adda T; Bertolani M; Roncoroni L; Bordi C
Dis Colon Rectum; 2004 Sep; 47(9):1467-82. PubMed ID: 15486743
[TBL] [Abstract][Full Text] [Related]
36. Expression of the cell-cell adhesion molecule beta-catenin in colorectal carcinomas and their metastases.
Buhmeida A; Elzagheid A; Algars A; Collan Y; Syrjänen K; Pyrhönen S
APMIS; 2008 Jan; 116(1):1-9. PubMed ID: 18254773
[TBL] [Abstract][Full Text] [Related]
37. Expression of p16 in lymph node metastases of adjuvantly treated stage III colorectal cancer patients identifies poor prognostic subgroups: a retrospective analysis of biomarkers in matched primary tumor and lymph node metastases.
Karamitopoulou E; Zlobec I; Koumarianou A; Patsouris ES; Peros G; Lugli A
Cancer; 2010 Oct; 116(19):4474-86. PubMed ID: 20572035
[TBL] [Abstract][Full Text] [Related]
38. Loss of Bcl-2 expression correlates with tumour recurrence in colorectal cancer.
Ilyas M; Hao XP; Wilkinson K; Tomlinson IP; Abbasi AM; Forbes A; Bodmer WF; Talbot IC
Gut; 1998 Sep; 43(3):383-7. PubMed ID: 9863484
[TBL] [Abstract][Full Text] [Related]
39. Prognostic impact of fascin-1 expression is more significant in advanced colorectal cancer.
Oh SY; Kim YB; Suh KW; Paek OJ; Moon HY
J Surg Res; 2012 Jan; 172(1):102-8. PubMed ID: 20851411
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathological significance of expression of p-c-Jun, TCF4 and beta-Catenin in colorectal tumors.
Takeda K; Kinoshita I; Shimizu Y; Ohba Y; Itoh T; Matsuno Y; Shichinohe T; Dosaka-Akita H
BMC Cancer; 2008 Nov; 8():328. PubMed ID: 18992165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]